Richard Kirsh
- Molecular Biology
- Immunology top 5%
- Biomaterials top 5%
- Virology top 2%
- Infectious Diseases top 5%
- Co-authors
- George PostePeter J. BugelskiIsaiah J. FidlerWilliam E. FoglerI. J. FidlerAvraham RazCorazon D. BucanaHarma Ellens
- Topics
- Nanoparticle-Based Drug Delivery (7 papers)HIV Research and Treatment (6 papers)HIV/AIDS drug development and treatment (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Controlled ReleaseAnnals of the New York Academy of Sciences
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Richard Kirsh
28 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 588
- Immunology 550
- Biomaterials 264
- Virology 260
- Infectious Diseases 257
Countries citing papers authored by Richard Kirsh
This map shows the geographic impact of Richard Kirsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kirsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kirsh more than expected).
Fields of papers citing papers by Richard Kirsh
This network shows the impact of papers produced by Richard Kirsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kirsh. The network helps show where Richard Kirsh may publish in the future.
Co-authorship network of co-authors of Richard Kirsh
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kirsh. A scholar is included among the top collaborators of Richard Kirsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kirsh. Richard Kirsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 18 | |
| 3 | 2 | |
| 4 | 185 | |
| 5 | 70 | |
| 6 | 2 | |
| 7 | 89 | |
| 8 | 22 | |
| 9 | 119 | |
| 10 | 5 | |
| 11 | Changes in the macrophage content of lung metastases at different stages in tumor growth. | 29 |
| 12 | 12 | |
| 13 | 124 | |
| 14 | Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. | 268 |
| 15 | Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease. | 2 |
| 16 | Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. | 149 |
| 17 | Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. | 58 |
| 18 | Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. | 106 |
| 19 | 4 | |
| 20 | 5 |
About Richard Kirsh
Richard Kirsh is a scholar working on Virology, Biomaterials and Biotechnology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Virology (260 citations), Immunology (550 citations) and Pharmaceutical Science (129 citations). Richard Kirsh has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include George Poste, Peter J. Bugelski, Isaiah J. Fidler, William E. Fogler, I. J. Fidler, Avraham Raz, Corazon D. Bucana, Harma Ellens, A. Raz and James F. Leary. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Controlled Release and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.